Abstract: In general, the invention features a novel CBM32-derived affinity scaffold. In certain embodiments, the scaffold comprises two types of regions: constant regions (CRs) and variable loop regions (VLRs) as depicted in the structure in FIG. 1. We have discovered that the CRs provide structural features that enable overall conformational stability while the intervening sequences corresponding to VLRs tolerate amino acid sequence randomization.
Type:
Grant
Filed:
August 24, 2015
Date of Patent:
February 16, 2021
Assignee:
Nectagen, Inc.
Inventors:
Richard J. Suderman, David M. Chao, Daren Rice